(兒科學(xué)英文課件)20 傳染性單核細(xì)胞增多癥_第1頁
(兒科學(xué)英文課件)20 傳染性單核細(xì)胞增多癥_第2頁
(兒科學(xué)英文課件)20 傳染性單核細(xì)胞增多癥_第3頁
(兒科學(xué)英文課件)20 傳染性單核細(xì)胞增多癥_第4頁
(兒科學(xué)英文課件)20 傳染性單核細(xì)胞增多癥_第5頁
已閱讀5頁,還剩63頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

InfectiousMononucleosis(IM)

monoHuangYanfeng,associateprofessorDIVISIONOFINFECTIOUSDISEASEOFCHONGQINGMEDICALUNIVERSITY

InfectiousMononucleosis(IM)

1IntroductionInfectiousmononucleosis(IM)isaninfectiousdiseasecausedbyEpstein-Barrvirus(EBV).Theclinicalfeaturesincludefever,pharyngitis,andgeneralizedlymphadenopathy.Thecharacteristicsoflabstudyisatypicallymphocytosisintheperipheralblood.

IntroductionInfectiousmononuc2EBVassociateddisease

TheupperrespiratorytractinfectionInfectiousmononucleosis(IM)EBVirus-associatedhemophagocyticlymphohistiocytosis(EBV-HLH)ChronicactiveEBVinfectionEBVirus-associatedmalignanttumor(Burkittlymphoma、Bcelllymphoma、Hodgkin'sdisease,nasopharyngealcarcinoma)EBVassociateddiseaseTheupp3(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥4(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥5Etiology3、ViralAntigenSystemsviralcapsidantigen,VCAEBnuclearantigen,EBNAearlyantigen,EAlymphocyte-detectedmembraneantigen,LYDMAmembraneantigen,MAEtiology3、ViralAntigenSystem6Epidemiology1.Infectioussources

Patients,personswithlatentinfectionandcarriers2.Routesoftransmission:Contacttransmissionthroughthemouth(exchangeofsaliva)bloodtransmissionoccasionally

3.PopulationsusceptibilitySchoolagechildrenandadolescents

4.EpidemiologicalfeaturesPeakseasonsEpidemiologicalstatusEpidemiology1.Infectioussour7傳染性單核細(xì)胞增多癥及其相關(guān)疾病臨床特點(diǎn)分析,中國實(shí)用兒科雜志,2003年12月第18卷12期兒童傳染性單核細(xì)胞增多癥臨床特點(diǎn)與發(fā)病年齡的關(guān)系附312例臨床分析,臨床兒科雜志,2011年6月第29卷6期6歲以下232例,占74.4%,6-15歲80例,占25.6%傳染性單核細(xì)胞增多癥及其相關(guān)疾病臨床特點(diǎn)分析,中國實(shí)用兒科雜8重慶醫(yī)科大學(xué)感染消化教研室重慶醫(yī)科大學(xué)感染消化教研室9Epidemiology1.Infectioussources

Patients,personswithlatentinfectionandcarriers2.Routesoftransmission:Contacttransmissionthroughthemouth(exchangeofsaliva)bloodtransmissionoccasionally

3.PopulationsusceptibilitySchoolagechildrenandadolescents

4.EpidemiologicalfeaturesPeakseasonsEpidemiologicalstatusEpidemiology1.Infectioussour10PathogenesisEBVsalivaryglands

infectsoralepithelialcellsandB-LCinpharynx

pharyngitisLymphadenopathyincervicalnodesexcreteEBVContinuouslyorintermittently

B-LCintheperipheralbloodandtheentirelymphoreticularsystem

viremia

ActivationofpolyclonalB-LC

polyclonalantibodiesSpecificAbsheterophilAbautoantibodyTcresponsedtotheinfectedB-LCEffectonB-LCcontainingEBVatypicalLC↑Hepatosplenomegaly,lymphadenectasis,myocarditis,pneumonia,etc.ChangesofantigenicityonthesurfaceofB-LC

TCLPathogenesisEBVsalivarygland11PathologyThebasicpathologicalchangeisthebenignlymphadenosisThemaindamageisinmonocyte-macrophagesystemLymphnodes:non-pyogeniclymphadenectasiswithLCandmonocyte-macrophagesystemproliferationSpleen:lotsofatypicalLCLCinfiltrationandlimitednecroticlesionsinorganssuchasliver,heart,kidney,lung,CNS,etc.PathologyThebasicpathologica12ManifestationsTheincubationperiod:5~15days1.Fever(>90%)2.pharyngitis:

80%.sorethroat,tonsillarenlargement,hyperemia,

edema

andexudates(50%)3.generalizedlymphadenopathy:80~100%.

Themostcommonlymphadenopathyisenlargementofcervicallymphnodes4.splenohepatomegalia:hepatomegaly:30~50%.

Amongthem,2/3haselevatedliverenzymesJaundiceisuncommon.

Liverfailuremayoccurredinfewcases.splenomegaly:50~70%5.rashes:10%6.others:stuffnose,snore,edemaoftheeyelids,etcManifestationsTheincubationp13Thetonsilsarehyperemicandedematouscoveredwithgray-whiteexudates.Thetonsilsarehyperemicand14(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥15ManifestationsTheincubationperiod:5~15days1.Fever(>90%)2.pharyngitis:

80%.sorethroat,tonsillarenlargement,hyperemia,

edema

andexudates(50%)3.generalizedlymphadenopathy:80~100%.

Themostcommonlymphadenopathyisenlargementofcervicallymphnodes4.splenohepatomegalia:hepatomegaly:30~50%.

Amongthem,2/3haselevatedliverenzymesJaundiceisuncommon.

Liverfailuremayoccurredinfewcases.splenomegaly:50~70%5.rashes:10%6.others:stuffnose,snore,edemaoftheeyelids,etcManifestationsTheincubationp16

cervicallymphnodes

17cervicallymphnodes

cervicallymphnodes

18ManifestationsTheincubationperiod:5~15days1.Fever(>90%)2.pharyngitis:

80%.sorethroat,tonsillarenlargement,hyperemia,

edema

andexudates(50%)3.generalizedlymphadenopathy:80~100%.

Themostcommonlymphadenopathyisenlargementofcervicallymphnodes4.splenohepatomegalia:hepatomegaly:30~50%.

Amongthem,2/3haselevatedliverenzymesJaundiceisuncommon.

Liverfailuremayoccurredinfewcases.splenomegaly:50~70%5.rashes:10%6.others:stuffnose,snore,edemaoftheeyelids,etcManifestationsTheincubationp19臨床表現(xiàn)臨床表現(xiàn)20(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥21文獻(xiàn)資料傳染性單核細(xì)胞增多癥及其相關(guān)疾病臨床特點(diǎn)分析,中國實(shí)用兒科雜志,2006年9月第21卷9期文獻(xiàn)資料22病例學(xué)習(xí)患兒,女,6歲,因”發(fā)熱、咽痛6天,頸部包塊4天”入院。6天前開始發(fā)熱,體溫可達(dá)39.8℃,無畏寒,寒戰(zhàn),訴咽痛,吞咽時(shí)明顯。2天后家人發(fā)現(xiàn)頸部包塊,不伴疼痛。輕咳,鼻阻明顯,打鼾。精神食欲尚可。院外予頭孢菌素(不詳)治療4天,無明顯好轉(zhuǎn)。無類似病人接觸史。查體:T39.5℃P123次/分R30次/分神情神可,熱病容,全身未見皮疹,眼瞼浮腫,雙側(cè)頸部各有3-4個(gè)腫大的淋巴結(jié),最大者直徑約2cm,質(zhì)中,咽充血明顯,扁桃體Ⅱ度腫大,可見白色滲出物附著,心肺聽診無異常,腹軟,肝臟肋下2cm,脾臟肋下2cm,質(zhì)地中,邊鈍。門診血常規(guī):WBC19.2*109/L,N0.23L0.58異型淋巴細(xì)胞

0.19。病例學(xué)習(xí)患兒,女,6歲,因”發(fā)熱、咽痛6天,頸部包塊4天”入23病例學(xué)習(xí)患兒,女,6歲,因“發(fā)熱、咽痛6天,頸部包塊4天”入院。6天前開始發(fā)熱,體溫可達(dá)39.8℃,無畏寒,寒戰(zhàn),訴咽痛,吞咽時(shí)明顯。2天后家人發(fā)現(xiàn)頸部包塊,不伴疼痛。輕咳,鼻阻明顯,打鼾。精神食欲尚可。院外診斷“扁桃體炎”予頭孢菌素(不詳)治療4天,無明顯好轉(zhuǎn)。無類似病人接觸史。查體:T39.5℃P123次/分R30次/分,神清神可,熱病容,全身未見皮疹,眼瞼浮腫,雙側(cè)頸部各有3-4個(gè)腫大的淋巴結(jié),最大者直徑約2cm,質(zhì)中,咽充血明顯,扁桃體Ⅱ度腫大,可見白色滲出物附著,心肺聽診無異常,腹軟,肝臟肋下2cm,脾臟肋下2cm,質(zhì)地中,邊鈍。門診血常規(guī):WBC19.2*109/L,N0.23,L0.58

異型淋巴細(xì)胞0.19。病例學(xué)習(xí)患兒,女,6歲,因“發(fā)熱、咽痛6天,頸部包塊4天”24Complicationsnervesystem:encephalitis,Guillain-Barrésyndrome,Reyesyndrome,Peripheralneuritis,etc.cardiovascularsystem:Myocarditis,pericarditishematologicalsystem:Hemolyticanemia,Aplasticanemia,thrombocytopenia,neutropenia,hemophagocyticsyndrome,etc.respiratorysystem:upperairwayobstruction,interstitialpneumonia,etc.urinarysystem:nephritis,nephroticsyndrome,etc.digestivesystem:gastrointestinalbleeding,liverfailure,etc.subcapsularsplenichemorrhageorsplenicruptureComplicationsnervesystem:ence25Labstudies1.bloodroutine:thereisleukocytosisof10–20×109/L,ofwhichatleast?arelymphocytes;atypicallymphocytesaccountfor≥10%relativelyor≥1.0×109/Labsolutelynotice:2.detectionofmarkersofEBVheterophilagglutinationtest

principlelimitationsdetectionofEBVAbs:EBV-VCAIgM3.detectionofnucleicacidofEBVbyPCR4.IsolationofEBVLabstudies1.bloodroutine:26atypicallymphocytesatypicallymphocytes27Labstudies1.bloodroutine:thereisleukocytosisof10–20×109/L,ofwhichatleast?arelymphocytes;atypicallymphocytesaccountfor≥10%relativelyor≥1.0×109/Labsolutelynotice:2.detectionofmarkersofEBVheterophilagglutinationtest

principlelimitationsdetectionofEBVAbs:EBV-VCAIgM3.detectionofnucleicacidofEBVbyPCR4.IsolationofEBVLabstudies1.bloodroutine:28heterophilagglutinationtestBeforetheadsorptionGuineapigkidneycellsafteradsorption

Cowredbloodcellsafteradsorption

IM++++++++—Serum

diseases+++——Normalorotherdiseases+—+heterophilagglutinationtest29Diagnosis1.IMtriadFever,pharyngitisandenlargementofcervicallymphnodes2.atypicallymphocytesaccountfor≥10%relativelyor≥1.0×109/Labsolutely3.heterophilagglutinationtestor/andEBV-VCAIgM(+)Diagnosis1.IMtriad30DifferentialDiagnosis1.suppurativetonsillitis2.infectiousmononucleosis-likesyndrom3.viralhepatitis4.Kawasakidisease5.LeukemiaDifferentialDiagnosis1.sup31Treatment1.generaltreatment2.symptomatictreatment3.antiviraltherapy:α-interferon、Acyclovir

Ganciclovir4.theuseofglucocorticoid:indicatorTreatment1.generaltreatment32Prognosis1.mostgoodprognosis2.fewpatientsprolongedcourse3.<1%ofpatientsdiePrognosis1.mostgoodprognosis33謝謝!謝謝!34InfectiousMononucleosis(IM)

monoHuangYanfeng,associateprofessorDIVISIONOFINFECTIOUSDISEASEOFCHONGQINGMEDICALUNIVERSITY

InfectiousMononucleosis(IM)

35IntroductionInfectiousmononucleosis(IM)isaninfectiousdiseasecausedbyEpstein-Barrvirus(EBV).Theclinicalfeaturesincludefever,pharyngitis,andgeneralizedlymphadenopathy.Thecharacteristicsoflabstudyisatypicallymphocytosisintheperipheralblood.

IntroductionInfectiousmononuc36EBVassociateddisease

TheupperrespiratorytractinfectionInfectiousmononucleosis(IM)EBVirus-associatedhemophagocyticlymphohistiocytosis(EBV-HLH)ChronicactiveEBVinfectionEBVirus-associatedmalignanttumor(Burkittlymphoma、Bcelllymphoma、Hodgkin'sdisease,nasopharyngealcarcinoma)EBVassociateddiseaseTheupp37(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥38(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥39Etiology3、ViralAntigenSystemsviralcapsidantigen,VCAEBnuclearantigen,EBNAearlyantigen,EAlymphocyte-detectedmembraneantigen,LYDMAmembraneantigen,MAEtiology3、ViralAntigenSystem40Epidemiology1.Infectioussources

Patients,personswithlatentinfectionandcarriers2.Routesoftransmission:Contacttransmissionthroughthemouth(exchangeofsaliva)bloodtransmissionoccasionally

3.PopulationsusceptibilitySchoolagechildrenandadolescents

4.EpidemiologicalfeaturesPeakseasonsEpidemiologicalstatusEpidemiology1.Infectioussour41傳染性單核細(xì)胞增多癥及其相關(guān)疾病臨床特點(diǎn)分析,中國實(shí)用兒科雜志,2003年12月第18卷12期兒童傳染性單核細(xì)胞增多癥臨床特點(diǎn)與發(fā)病年齡的關(guān)系附312例臨床分析,臨床兒科雜志,2011年6月第29卷6期6歲以下232例,占74.4%,6-15歲80例,占25.6%傳染性單核細(xì)胞增多癥及其相關(guān)疾病臨床特點(diǎn)分析,中國實(shí)用兒科雜42重慶醫(yī)科大學(xué)感染消化教研室重慶醫(yī)科大學(xué)感染消化教研室43Epidemiology1.Infectioussources

Patients,personswithlatentinfectionandcarriers2.Routesoftransmission:Contacttransmissionthroughthemouth(exchangeofsaliva)bloodtransmissionoccasionally

3.PopulationsusceptibilitySchoolagechildrenandadolescents

4.EpidemiologicalfeaturesPeakseasonsEpidemiologicalstatusEpidemiology1.Infectioussour44PathogenesisEBVsalivaryglands

infectsoralepithelialcellsandB-LCinpharynx

pharyngitisLymphadenopathyincervicalnodesexcreteEBVContinuouslyorintermittently

B-LCintheperipheralbloodandtheentirelymphoreticularsystem

viremia

ActivationofpolyclonalB-LC

polyclonalantibodiesSpecificAbsheterophilAbautoantibodyTcresponsedtotheinfectedB-LCEffectonB-LCcontainingEBVatypicalLC↑Hepatosplenomegaly,lymphadenectasis,myocarditis,pneumonia,etc.ChangesofantigenicityonthesurfaceofB-LC

TCLPathogenesisEBVsalivarygland45PathologyThebasicpathologicalchangeisthebenignlymphadenosisThemaindamageisinmonocyte-macrophagesystemLymphnodes:non-pyogeniclymphadenectasiswithLCandmonocyte-macrophagesystemproliferationSpleen:lotsofatypicalLCLCinfiltrationandlimitednecroticlesionsinorganssuchasliver,heart,kidney,lung,CNS,etc.PathologyThebasicpathologica46ManifestationsTheincubationperiod:5~15days1.Fever(>90%)2.pharyngitis:

80%.sorethroat,tonsillarenlargement,hyperemia,

edema

andexudates(50%)3.generalizedlymphadenopathy:80~100%.

Themostcommonlymphadenopathyisenlargementofcervicallymphnodes4.splenohepatomegalia:hepatomegaly:30~50%.

Amongthem,2/3haselevatedliverenzymesJaundiceisuncommon.

Liverfailuremayoccurredinfewcases.splenomegaly:50~70%5.rashes:10%6.others:stuffnose,snore,edemaoftheeyelids,etcManifestationsTheincubationp47Thetonsilsarehyperemicandedematouscoveredwithgray-whiteexudates.Thetonsilsarehyperemicand48(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥49ManifestationsTheincubationperiod:5~15days1.Fever(>90%)2.pharyngitis:

80%.sorethroat,tonsillarenlargement,hyperemia,

edema

andexudates(50%)3.generalizedlymphadenopathy:80~100%.

Themostcommonlymphadenopathyisenlargementofcervicallymphnodes4.splenohepatomegalia:hepatomegaly:30~50%.

Amongthem,2/3haselevatedliverenzymesJaundiceisuncommon.

Liverfailuremayoccurredinfewcases.splenomegaly:50~70%5.rashes:10%6.others:stuffnose,snore,edemaoftheeyelids,etcManifestationsTheincubationp50

cervicallymphnodes

51cervicallymphnodes

cervicallymphnodes

52ManifestationsTheincubationperiod:5~15days1.Fever(>90%)2.pharyngitis:

80%.sorethroat,tonsillarenlargement,hyperemia,

edema

andexudates(50%)3.generalizedlymphadenopathy:80~100%.

Themostcommonlymphadenopathyisenlargementofcervicallymphnodes4.splenohepatomegalia:hepatomegaly:30~50%.

Amongthem,2/3haselevatedliverenzymesJaundiceisuncommon.

Liverfailuremayoccurredinfewcases.splenomegaly:50~70%5.rashes:10%6.others:stuffnose,snore,edemaoftheeyelids,etcManifestationsTheincubationp53臨床表現(xiàn)臨床表現(xiàn)54(兒科學(xué)英文課件)20傳染性單核細(xì)胞增多癥55文獻(xiàn)資料傳染性單核細(xì)胞增多癥及其相關(guān)疾病臨床特點(diǎn)分析,中國實(shí)用兒科雜志,2006年9月第21卷9期文獻(xiàn)資料56病例學(xué)習(xí)患兒,女,6歲,因”發(fā)熱、咽痛6天,頸部包塊4天”入院。6天前開始發(fā)熱,體溫可達(dá)39.8℃,無畏寒,寒戰(zhàn),訴咽痛,吞咽時(shí)明顯。2天后家人發(fā)現(xiàn)頸部包塊,不伴疼痛。輕咳,鼻阻明顯,打鼾。精神食欲尚可。院外予頭孢菌素(不詳)治療4天,無明顯好轉(zhuǎn)。無類似病人接觸史。查體:T39.5℃P123次/分R30次/分神情神可,熱病容,全身未見皮疹,眼瞼浮腫,雙側(cè)頸部各有3-4個(gè)腫大的淋巴結(jié),最大者直徑約2cm,質(zhì)中,咽充血明顯,扁桃體Ⅱ度腫大,可見白色滲出物附著,心肺聽診無異常,腹軟,肝臟肋下2cm,脾臟肋下2cm,質(zhì)地中,邊鈍。門診血常規(guī):WBC19.2*109/L,N0.23L0.58異型淋巴細(xì)胞

0.19。病例學(xué)習(xí)患兒,女,6歲,因”發(fā)熱、咽痛6天,頸部包塊4天”入57病例學(xué)習(xí)患兒,女,6歲,因“發(fā)熱、咽痛6天,頸部包塊4天”入院。6天前開始發(fā)熱,體溫可達(dá)39.8℃,無畏寒,寒戰(zhàn),訴咽痛,吞咽時(shí)明顯。2天后家人發(fā)現(xiàn)頸部包塊,不伴疼痛。輕咳,鼻阻明顯,打鼾。精神食欲尚可。院外診斷“扁桃體炎”予頭孢菌素(不詳)治療4天,無明顯好轉(zhuǎn)。無類似病人接觸史。查體:T39.5℃P123次/分R30次/分,神清神可,熱病容,全身未見皮疹,眼瞼浮腫,雙側(cè)頸部各有3-4個(gè)腫大的淋巴結(jié),最大者直徑約2cm,質(zhì)中,咽充血明顯,扁桃體Ⅱ度腫大,可見白色滲出物附著,心肺聽診無異常,腹軟,肝臟肋下2cm,脾臟肋下2cm,質(zhì)地中,邊鈍。門診血常規(guī):WBC19.2*109/L,N0.23,L0.58

異型淋巴細(xì)胞0.19。病例學(xué)習(xí)患兒,女,6歲,因“發(fā)熱、咽痛6天,頸部包塊4天”58Complicationsnervesystem:encephalitis,Guillain-Barrésyndrome,Reyesyndrome,Peripheralneuritis,etc.cardiovascularsystem:Myocarditis,pericarditishematologicalsystem:Hemolyticanemia,Aplasticanemia,thrombocytopenia,neutropenia,hemophagocyticsyndrome,etc.respiratorysystem:upperairwayobstruction,interstitialpneumonia,etc.urinarysystem:nephritis,nephroticsyndrome,etc.digestivesystem:gastrointestinalbleeding,liverfailure,etc.subcapsularsplenichemorrhageorsplenicruptureComplicationsnervesystem:ence59Labstudies1.bloodroutine:thereisleukocytosisof10–20×109/L,ofwhichatleast?arelymphocytes;atypicallymphocytesaccountfor≥10%relativelyor≥1.0×109/Labsolutelynotic

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論